HALOVATE LOTION contains Halobetasol which belongs to the group of medicines called Topical Corticosteroids. HALOVATE LOTION is used in the treatment of plaque psoriasis in patients.
Plague psoriasis is an autoimmune disease that cause your cells to reproduce very quickly resulting in thick, scaly patches on skin called plaques which is generally characterized by symptoms such as raised, discolored (red, brown, gray or purple) plaques with a white or silvery surface, cracks (fissures), bleeding, itchiness, irritation, and or pain which most commonly occurs on elbow, back, knees, and scalp.
Along with this treatment, your doctor might advise you to take an ACTH (adrenocorticotropic hormone) stimulation test to evaluate HPA axis suppression (a condition that causes poor body defense against infection) especially in children to prevent its effect in the body.
Avoid applying HALOVATE LOTION, if you are allergic to Halobetasol. Before applying HALOVATE LOTION, inform your doctor if you have cataract, kidney, and or liver problems.
HALOVATE LOTION should be used with caution in pregnant and breastfeeding women only if it is necessary. The efficacy and safety of HALOVATE LOTION have not been established in pediatric patients. Consult your doctor before applying HALOVATE LOTION.
The most common side effects of applying HALOVATE LOTION are telangiectasia (small, widened blood vessels on skin), application site atrophy, and headache. Contact your doctor if any of the above side effects worsen.
HALOVATE LOTION possesses anti-inflammatory, anti-pruritic and vasoconstrictive properties. It induces phospholipase A2 inhibitory proteins such as lipocortins. The protein inhibits the biosynthesis of pro-inflammatory mediators such as leukotrienes and prostaglandins by inhibiting arachidonic acid, a precursor of pro-inflammatory mediators.
Apply HALOVATE LOTION as directed by your doctor. It is for external use only. Apply a thin layer of this medicine to the affected skin twice daily and rub in gently. It should not be used for more than 2 weeks. Consult your doctor for advice.
Stop applying HALOVATE LOTION and contact your doctor immediately if you experience any of the following side effects:
If HALOVATE LOTION causes headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking HALOVATE LOTION. If headache last more than a week or severe, inform your doctor.
There are no adequate and well-controlled studies of HALOVATE LOTION in pregnant women. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Consult your doctor before applying HALOVATE LOTION.
Caution should be exercised when HALOVATE LOTION is administered to a nursing woman. Consult your doctor before applying HALOVATE LOTION.
HALOVATE LOTION should be used with caution in patients with kidney problems. Consult your doctor before applying HALOVATE LOTION.
HALOVATE LOTION should be used with caution in patients with liver problems. Consult your doctor before applying HALOVATE LOTION.
HALOVATE LOTION is not recommended for use if you are allergic to Halobetasol or any other ingredients in the medicine. Consult your doctor before applying HALOVATE LOTION.
The efficacy and safety of HALOVATE LOTION have not been established in pediatric patients. Consult your doctor before applying HALOVATE LOTION.
HALOVATE LOTION should be used with caution in elderly patients (aged 65 years or above). Consult your doctor before applying HALOVATE LOTION.
Before applying HALOVATE LOTION, inform your doctor if you have:
A. Drug-Drug Interactions:
Before applying HALOVATE LOTION, inform your doctor, if you are taking any of the medicine including prescription, non-prescription and herbal supplements.
Overdosage:
If you or anyone else accidentally uses too much HALOVATE LOTION, consult your doctor immediately or visit the nearby hospital.
Drug | : | Halobetasol |
Pharmacological Category | : | Topical Corticosteroids |
Therapeutic Indication | : | Plaque psoriasis |
Dosage Forms | : | Cream, Ointment, Lotion, Gel |
Q: What HALOVATE LOTION is used for?
A: HALOVATE LOTION is used in the treatment of plaque psoriasis in patients. Plague psoriasis is an autoimmune disease that cause your cells to reproduce very quickly resulting in thick, scaly patches on skin called plaques which is generally characterized by symptoms such as raised, discolored (red, brown, gray or purple) plaques with a white or silvery surface, cracks (fissures), bleeding, itchiness, irritation, and or pain which most commonly occurs on elbow, back, knees, and scalp.
Q: How HALOVATE LOTION is applied on the affected site?
A: Apply HALOVATE LOTION as directed by your doctor. It is for external use only. Wash your hands before and after use to ensure hygiene is maintained. Avoid contact of this medicine in your eyes, ears, nose, mouth. Your doctor will decide the duration of treatment depending upon the severity of the condition.
Q: What are the side effects of HALOVATE LOTION?
A: The most common side effects of applying HALOVATE LOTION are telangiectasia (small widened blood vessels on skin), application site atrophy, and headache. Contact your doctor if any of the symptoms worsen.
Q: Is HALOVATE LOTION safe to use in children?
A: The efficacy and safety of HALOVATE LOTION have not been established in pediatric patients. Consult your doctor before applying HALOVATE LOTION.
Q: Is HALOVATE LOTION safe to use in pregnant and breastfeeding women?
A: HALOVATE LOTION should be used with caution in pregnant and breastfeeding women only if it is clearly advised by your doctor. Consult your doctor before applying HALOVATE LOTION.
1. Constance G Visovsky, Cheryl H Zambroski, Rebecca M. Lutz. Integumentary System Medications. Edmunds' Pharmacology for the Primary Care Provider - E-Book. 2022. Page – 34.
2. Halobetasol. NIH National Library of Medicine. National Center for Biotechnology Information. PubChem. June 2022. [Accessed on 13th April 2022] https://pubchem.ncbi.nlm.nih.gov/compound/Halobetasol#section=Biological-Half-Life
3. Halobetasol Lotion, Cream and Ointment Monograph. Pharmacy Benefits Management Services. [Revised in October 2016] [Accessed on 13th April 2022] https://www.pbm.va.gov/PBM/clinicalguidance/drugmonographs/Halobetasol_ULTRAVATE_Lotion_Cream_Ointment_Monograph.pdf
4. ULTRAVATE- halobetasol propionate lotion. DailyMed. NIH U.S. National Library of Medicine. September 2020. [Accessed on 13th April 2022] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0d563d44-17fd-4976-9f2c-f1d509f29587
5. Sun Pharmaceutical Industries. U.S. Food & Drug Administration. [Revised in August 2020] [Accessed on 13th April 2022] https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021688s017lbl.pdf
Written By Dr. Janet.C, Pharm.D
Last updated on 09 Mar 2023 | 12:16 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.